**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: January 12, 1995
* Medical Record Number: 123456
* Admission Date: March 10, 2023
* Discharge Date: March 20, 2023
* Discharge Summary Written by: [Your Name], MD, Endocrinology Unit

**Medical History:**

John Doe, a 28-year-old male, was admitted to our endocrinology unit on March 10, 2023, with a chief complaint of increasing thirst, hunger, and frequent urination over the past 2 weeks. He reported a 10-pound weight loss over the same period. His family history is significant for type 2 diabetes in his mother.

**Admission Diagnosis:**

The patient was diagnosed with type 1 diabetes mellitus based on the following laboratory results:

* Fasting plasma glucose (FPG) level: 450 mg/dL (25 mmol/L)
* Glycosylated hemoglobin (HbA1C): 12.5%
* Random plasma glucose: 350 mg/dL (19.4 mmol/L)

**Hospital Course:**

The patient was started on insulin therapy with a basal-bolus regimen, consisting of:

* Lantus (insulin glargine) 20 units subcutaneously at 12:00 AM
* Humalog (insulin lispro) 10 units subcutaneously before meals (3 times a day)

He was also prescribed metformin 500 mg orally twice a day for glycemic control.

**Dietary Recommendations:**

The patient was educated on a personalized diet plan, focusing on whole foods and high-quality carbohydrates. He was advised to aim for 150-200 grams of carbohydrate per meal and to space out his meals to maintain stable blood glucose levels.

**Exercise Recommendations:**

The patient was recommended to engage in physical activity of at least 150 minutes per week, with a focus on aerobic exercise such as brisk walking, cycling, or swimming. He was advised to check his blood glucose levels before and after exercise and to adjust his insulin doses or carbohydrate intake as needed to manage hypoglycemia risk.

**Foot Care and Complications Screening:**

The patient was educated on the importance of regular foot examinations to check for signs of peripheral neuropathy. He was also screened for diabetic complications, including retinopathy, nephropathy, and cardiovascular disease.

**Discharge Instructions:**

Upon discharge, the patient was instructed to:

* Monitor his blood glucose levels regularly and adjust his insulin doses as needed
* Attend regular follow-up appointments with his primary care physician and endocrinologist
* Maintain a healthy diet and exercise regimen
* Monitor for signs and symptoms of hypoglycemia and hyperglycemia
* Report any changes in his condition to his healthcare providers immediately

**Medications:**

The patient was discharged on the following medications:

* Lantus (insulin glargine) 20 units subcutaneously at 12:00 AM
* Humalog (insulin lispro) 10 units subcutaneously before meals (3 times a day)
* Metformin 500 mg orally twice a day

**Follow-up:**

The patient is scheduled for a follow-up appointment with his endocrinologist in 2 weeks to monitor his glycemic control and adjust his treatment plan as needed.

**Conclusion:**

John Doe was diagnosed with type 1 diabetes mellitus and was started on insulin therapy with a basal-bolus regimen. He was educated on dietary recommendations, exercise guidelines, and foot care. He was also screened for diabetic complications and instructed on the importance of regular follow-up appointments. With proper management and education, the patient is expected to achieve good glycemic control and prevent complications associated with type 1 diabetes.